The good governance for medicines programme (GGM) leads WHO’s efforts to reduce corruption in the health sector. Its goal is to contribute to health systems strengthening and to prevent. health — loss of government capacity to provide access to good-quality essential medicines.

The appointed leaders will oversee six newly created regions comprised of the twelve sub-regions that make up Cognizant’s Global Growth Markets (GGM). The regional leaders will focus on driving better alignment across countries and deliver a more engaging experience for clients.

2024年7月15日 · Here, we developed a single-cell graphical Gaussian model (SingleCellGGM) algorithm to conduct single-cell gene co-expression network analysis. When applied to mouse single-cell datasets, SingleCellGGM constructed networks from which gene co-expression modules with highly significant functional enrichment were identified.

The appointed leaders will oversee six newly created regions comprised of the twelve sub-regions that make up Cognizant’s Global Growth Markets (GGM). The regional leaders will focus on driving better alignment across countries and deliver a more engaging experience for clients.

contribution to the development of this model framework by giving their valuable insights and feed - back on the draft versions and/or sharing the GGM experiences and successful examples in their countries.

WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and recommendations.

Governance for Medicines (GGM) programme in order to reduce corruption in pharmaceutical systems. It was implemented in 3 phases: (i) National assessment of ethical practices in medicines registration and procurement to improve transparency and good governance in pharmaceutical system (ii) Development of GGM framework and

2014年1月21日 · Recognizing that good governance matters for improved health outcomes and return on development investments, global institutions like the World Bank, the WHO’s Good Governance for Medicines Programme (GGM), the Global Fund for HIV/AIDS, Tuberculosis, and Malaria (Global Fund), and the UK Department for International Development (DFID) through ...

The WHO Good Governance for Medicines (GGM) pro-gramme was launched in 2004 and extends to 16 countries from the WHO Eastern Mediterranean Region (1). The overall objectives of the programme are to improve good governance, prevent corruption in the pharmaceutical sector and contribute to health systems strengthening in countries.

2023年8月17日 · Cognizant Technology Solutions has restructured its global growth markets (GGM) by appointing two internal leaders who will now share the responsibility. The move follows the exit of former GGM leader Rob Walker last month and is among the slew of leadership changes the company has seen in the recent past.